Internal Medicine
Partner With Us
Advertisement

Rheumatology

thumb description

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

thumb description

March 31, 2025

Cold Plunges: A Cellular Reset?

New research shows that 1 week of daily cold-water immersion enhances autophagy and reduces cell death signals.

Conexiant

thumb description

March 27, 2025

RA and axSpA Tied to Depression, Anxiety in Large Study

Individuals with autoimmune arthritides are more likely to experience mood and anxiety disorders—even relative to counterparts with other chronic illnesses—according to a national cohort study.

Conexiant

thumb description

March 27, 2025

Hip Replacement with Few Signs of OA

A study finds that total hip arthroplasty in patients with minimal radiographic osteoarthritis results in high satisfaction but lower functional outcomes, with only 33% achieving a patient-acceptable symptom state.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

thumb description

March 21, 2025

FDA Approves Guselkumab for Crohn’s Disease

The FDA has approved guselkumab (TREMFYA®) for moderately to severely active Crohn’s disease, supported by Phase 3 trial data showing clinical and endoscopic superiority over ustekinumab.

Conexiant